[Microbiota and autoimmune processes as potential therapeutic targets in comorbid depression and inflammatory bowel disease]. / Mikrobiota i autoimmunnye protsessy kak potentsial'nye terapevticheskie «misheni¼ pri komorbidnosti depressii i vospalitel'nykh zabolevanii kishechnika.
Zh Nevrol Psikhiatr Im S S Korsakova
; 121(12): 134-138, 2021.
Article
em Ru
| MEDLINE
| ID: mdl-35041326
The aim of this review is to evaluate current information on the shared pathologic mechanisms of inflammatory bowel disease (IBD) and depression, with an emphasis on inflammatory mechanisms and the role of the gut microbiota. According to the recent data, abovementioned elements play an important role in the risks of depression and anxiety in IBD. The impact on inflammatory processes and microbiota can be used to develop new therapeutic approaches both in cases of comorbid and isolated mental pathology. Despite this, the number of high-quality clinical studies in this area is currently extremely small. Further research into colitis-associated inflammation and dysbiosis may be the key to further understanding and creating optimal treatment of comorbid diseases.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Doenças Inflamatórias Intestinais
/
Colite
/
Microbiota
Limite:
Humans
Idioma:
Ru
Revista:
Zh Nevrol Psikhiatr Im S S Korsakova
Assunto da revista:
NEUROLOGIA
/
PSIQUIATRIA
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Federação Russa
País de publicação:
Federação Russa